Search

Your search keyword '"Lübbert, A."' showing total 2,731 results

Search Constraints

Start Over You searched for: Author "Lübbert, A." Remove constraint Author: "Lübbert, A." Search Limiters Full Text Remove constraint Search Limiters: Full Text
2,731 results on '"Lübbert, A."'

Search Results

1. The miscalibration of the honeybee odometer

7. Measurable residual disease monitoring in AML with FLT3-ITD treated with intensive chemotherapy plus midostaurin

8. Serum uromodulin associates with kidney function and outcome in a cohort of hospitalised COVID-19 patients

10. Continued decitabine/all-trans retinoic acid treatment: extended complete remission in an elderly AML patient with multi-hit TP53 lesions and complex-monosomal karyotype

11. Predicting social experience from dyadic interaction dynamics: the BallGame, a novel paradigm to study social engagement

12. Clinical management, pathogen spectrum and outcomes in patients with pyogenic liver abscess in a German tertiary-care hospital

13. Refinement of the prognostic impact of somatic CEBPA bZIP domain mutations in acute myeloid leukemia: Results of the AML Study Group (AMLSG)

14. Measurable residual disease monitoring in AML with FLT3-ITD treated with intensive chemotherapy plus midostaurin

16. Long-term decitabine/retinoic acid maintenance treatment in an elderly sAML patient with high-risk genetics

17. DNMT and HDAC inhibition induces immunogenic neoantigens from human endogenous retroviral element-derived transcripts

18. Development of combination therapies with BTK inhibitors and dasatinib to treat CNS-infiltrating E2A-PBX1+/preBCR+ ALL

20. Hyperimmune immunoglobulin for hospitalised patients with COVID-19 (ITAC): a double-blind, placebo-controlled, phase 3, randomised trial

21. Presence of hypervirulence-associated determinants in Klebsiella pneumoniae from hospitalised patients in Germany

22. Evaluation of organized atrial arrhythmias after cryptogenic stroke

24. Presence of hypervirulence-associated determinants in Klebsiella pneumoniae from hospitalised patients in Germany

25. Estimating and comparing adverse event probabilities in the presence of varying follow-up times and competing events

27. DNMT and HDAC inhibition induces immunogenic neoantigens from human endogenous retroviral element-derived transcripts

30. Individuals at risk for severe COVID-19 in whom ritonavir-containing therapies are contraindicated or may lead to interactions with concomitant medications: a retrospective analysis of German health insurance claims data

31. Chylothorax due to hepatic alveolar echinococcosis with infiltration of diaphragm and left pleura: a case report

34. Comparative Analysis of Lymphocyte Populations in Post-COVID-19 Condition and COVID-19 Convalescent Individuals

35. Respiratory Syncytial Virus in Adult Patients at a Tertiary Care Hospital in Germany: Clinical Features and Molecular Epidemiology of the Fusion Protein in the Severe Respiratory Season of 2022/2023

36. Beyond kindness: a proposal for the flourishing of science and scientists alike

37. Netboost: Boosting-supported network analysis improves high-dimensional omics prediction in acute myeloid leukemia and Huntington's disease

38. Epidemiology of Clostridioides difficile Infections in Germany, 2010–2019: A Review from Four Public Databases

39. Microbiological Findings and Clinical Outcomes in Ugandan Patients with Infected Burn Wounds

41. Absence of early platelet increment in healthy mice during decitabine treatment

42. COVID-19 treatment strategies with drugs centrally procured by the German Federal Ministry of Health in a representative tertiary care hospital: a temporal analysis

43. S120: MNX1-ACTIVATING ENHANCER HIJACKING EVENTS IN ACUTE MYELOID LEUKEMIA WITH DELETIONS ON CHROMOSOME 7Q

44. S135: NEXT-GENERATION SEQUENCING-BASED MEASURABLE RESIDUAL DISEASE MONITORING IN ACUTE MYELOID LEUKEMIA WITH FLT3 INTERNAL TANDEM DUPLICATION TREATED WITH INTENSIVE CHEMOTHERAPY PLUS MIDOSTAURIN

45. P480: DNMT AND HDAC INHIBITION INDUCES IMMUNOGENIC NEOANTIGENS FROM HUMAN ENDOGENOUS RETROVIRAL ELEMENT-DERIVED TRANSCRIPTS

46. P719: RANDOMIZED PHASE 1-2 STUDY TO ASSESS SAFETY AND EFFICACY OF LOW-DOSE (LD) ORAL DECITABINE/CEDAZURIDINE (ASTX727) IN LOWER-RISK MYELODYSPLASTIC SYNDROMES (LR-MDS) PATIENTS: INTERIM SAFETY ANALYSIS

47. Early-Outcome Differences between Acute and Chronic Periprosthetic Joint Infections—A Retrospective Single-Center Study

48. Metabolic shift towards increased biohydrogen production during dark fermentation in the anaerobic fungus Neocallimastix cameroonii G341

49. The antileukemic activity of decitabine upon PML/RARA-negative AML blasts is supported by all-trans retinoic acid: in vitro and in vivo evidence for cooperation

50. Predictive performance and clinical application of COV50, a urinary proteomic biomarker in early COVID-19 infection: a prospective multicentre cohort study

Catalog

Books, media, physical & digital resources